Smart pain tracking may ease recovery after C-Sections

NCT ID NCT07720440

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial tests whether a device that measures the body's pain signals during surgery can help doctors give just the right amount of pain medicine during C-sections. Sixty women having planned C-sections under general anesthesia will be randomly assigned to either standard monitoring or the Nociception Level Index-guided approach. The goal is to see if this leads to less pain after surgery, lower need for extra painkillers, and earlier first breastfeeding.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Nociception Level Index Monitoring device used to guide fentanyl dosing during cesarean section
What this could lead to
If effective, this approach could offer better pain control after C-sections and faster recovery for new mothers.
What could go wrong
This is a small, early-stage trial with 60 participants. The device may not improve pain outcomes over standard care, and results may not apply to all C-sections.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CESAREAN SECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Breast Feeding Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Health Sciences Türkiye Haseki Training and Research Hospital

    Istanbul, Sultangazi, 34256, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.